Pharma’s Digital Disruptor: How virtual trials are transforming the clinical research experience

October 2, 2019

Virtual Trial models bring clinical research directly to patients to reduce burdens and improve engagement. These innovative models offer operational flexibility to better meet the unique needs of a trial and its key stakeholders. In this webinar, we will discuss: * How early adopter studies are applying virtual trial models in different ways to achieve […]

Best Practices for Launching a Successful and Compliant Clinical Nurse Educator Program

September 17, 2019

Starting a new or complex therapy isn’t easy. Often, patients’ #1 concern is understanding the side effects of their medication and how it may impact their daily life. The need for patient support is greater than ever, but it’s how you provide that support that can make the difference. This webinar will dive deeper into […]

Digital Health: Disruptive Technology or Just a Disruption?

September 16, 2019

Digital technology is redefining every segment of healthcare—from drug discovery and clinical trials to patient treatment and monitoring.  Healthcare, biotechnology and pharmaceuticals all make the top-five list of industries facing the greatest digital disruption over the next three years.  What are the full implications of the digital revolution for life sciences companies? How are business […]

RWE in an Evolving Regulatory Landscape: Using Real-World Evidence to Support Novel Product Development Pathways

August 27, 2019

The growing interest in RWE from both regulators and payors, along with innovative data models and technologies, has the potential to transform clinical research as we know it. Particularly for rare diseases, the opportunity to utilize existing data and to link patients across multiple datasets, in concert with proven prospective research models within non-traditional infrastructure […]

Promotional Review Best Practices: Mitigating Risks, Maximizing Success

August 12, 2019

Discover How to Meet Commercial Goals While Complying with FDA and FTC Regulations. The promotional review process requires a critical balance between ensuring materials achieve business goals and complying with regulatory constraints. There often can be friction on the promotional review committee (PRC) between the marketing team and participants representing medical, legal and regulatory issues. […]

Save Time and Reduce Costs in Procurement and Outsourcing Using Technology

August 6, 2019

Exploring ways to use technology and structured information to evaluate potential business partners, create projects, solicit bids, provide proposal process feedback, and ultimately making the procurement and outsourcing process better for everyone involved. This event will provide valuable insights for companies looking to procure or outsource services as well as companies providing those services. Be […]

Medical Storytelling Through Data: More Than Just Information Transfer

May 15, 2019

This webinar will cover the following objectives. 1. Recognize the boundaries—in addition to knowledge—that shape and change HCP behaviors 2. Identify new strategic frameworks that can help drive your future medical education plans 3. Measure, evaluate, and refine your medical education tactics to ensure they meet your strategic objectives Who Should Attend? Marketing Management Product […]

Machine Learning for Patient Forecasting and Site Selection

April 26, 2019

The clinical development marketplace continues to become more complex and competitive, with stricter regulatory standards and trial oversight—all the while demanding patient-centric drug development.  These, and other factors, contribute to  unsustainable costs and longer timelines before much-needed therapies reach the market.  As the industry looks to technology to drive efficiencies and reduce costs—machine learning continually […]

Improving Clinical Trial Milestones and Reducing Site Burden with Clinical Trial Nurse Educators

April 9, 2019

The growing complexity of clinical trials—with intensified regulatory standards and the need to enroll highly segmented patient populations—causes delays in as many as 90% of trials. With the enormous growth in the development of specialty medicines today, manufacturers have an opportunity to utilize higher-touch, more patient-centric training initiatives in trial protocols to ensure that investigators […]

Transform Teams, Programs, and Services: An experience strategy primer to reset your focus and accelerate business objectives

April 1, 2019

As the pharmaceutical industry moves beyond the pill and seeks opportunities to deliver more novel, sustainable value to customers and patients, human-centered design becomes more relevant to research, patient advocacy, and market access teams than ever. To this end, customer and patient engagement strategies grounded in service design methods become uniquely powerful aids for navigating […]

Reaching for 99% compliance and engagement in clinical trials

March 20, 2019

Patient engagement and participation rates drive the speed and cost of clinical trials. Improving compliance and retention reduces costs, improves data quality, achieves earlier study-lock, and reduces costly failures. Initial industry efforts with modern mobile digital tools suggest that dramatic improvements in compliance and retention are possible. Still, despite some notable examples, we also see […]

Designing and Measuring Engagement in Behavior Change Interventions

January 15, 2019

Engagement is a prerequisite to any successful behavior change intervention, but engagement alone doesn’t guarantee a beneficial outcome. If we want to improve outcomes by improving engagement, we need a clear understanding of what characterizes meaningful engagement, how to design for it, and how to measure it. Despite designers’ every effort to convince, entice, seduce, […]

Building a Secure, Automated Quality System to Accelerate Time to Market

September 17, 2018

Today life science companies face a perfect storm of factors driving their costs up and sales down. With 40% of R&D costs linked to paper-based processes, legacy, manual processes pose a particular threat – costing life science companies billions of dollars a year and delaying product launch and commercialization*. Boston Scientific is tackling these challenges […]

Medical Storytelling: Combining High Science and High Emotion for High Impact

August 28, 2018

During this presentation, the speakers will share their insights on transforming medical education content from a package insert rehash into a compelling, compliant medical story. They will highlight how you can take healthcare provider audiences from being passive listeners to active participants by Capturing and keeping their attention, reception, and recall Provocatively challenging healthcare providers […]

The Future of Work is Now. Are you Ready?

August 9, 2018

In today’s rapidly changing market, organizations and workforce experts alike are trying to determine how the future of work will transform. Based on conversations across the market and our in-depth research, KellyOCG has determined that there are four dimensions organizations need to consider when contemplating the “Future of Work”: technology, the workforce (including the multiple […]

Unlocking the potential of online communities – looking beyond the surface

August 3, 2018

While online communities have emerged as a critical component of understanding the experiences of people living with chronic conditions, there is so much more to learn and uncover beneath the surface. In this webinar, Health Union, a pioneer in creating open, online health communities (19 and counting), including migraine.com, multiplesclerosis.net and lungcancer.net, discusses the how […]

Addressing Unmet Needs of Patients and Providers in Rare and Complex Disease

August 3, 2018

As the growth of rare and complex disease continues to skyrocket, more than ever, pharmaceutical manufacturers must address the unique challenges of providers and their patients to differentiate their brand. Providers and their staff have a lack of knowledge; they face continued time constraints, and with the growth of new products it’s difficult to keep […]

Patients as Partners: Imagining the Future of Rare Disease Therapies

May 23, 2018

This is the first installment of our new webinar series, Healthy Opinions. It is now available to watch any time as an OnDemand resource. Healthy Opinions covers important topics in the life sciences industry. We feature top thought leaders and experts in a panel format. All panelists participate using their webcam. The focus of this […]

Improving patient engagement through design psychology principles

March 21, 2018

For years, we’ve been hearing that digital health is the future, but so far, patient engagement has been low. Research on digital health interventions has generally found lack-luster usage and retention over time.  Yet we all know that successful evidence-based interventions that support better health, including medication adherence, lifestyle changes, and symptom management are very […]

Driving improved access and compliance through direct-to-physician sampling

March 5, 2018

For many commercial teams, accessing physicians for sample distribution has never been more challenging. Over the past 10 years, the number of physicians who are accessible to pharma sales teams has declined by nearly half. As a result, many companies are shifting to direct-to-physician (DTP) sampling programs to help overcome access and compliance concerns. In […]

How to Challenge the Status Quo in Highly Competitive Markets

February 2, 2018

Are the entrenched habits of physicians limiting your product’s growth? Grow your brand appropriately by Challenging the Status Quo. Quantum’s “Challenge the Status Quo” approach shows salespeople and their managers how to change physicians’ thinking and treatment habits in 4 steps:       Supplying the energy to change. No one changes without motivation or energy. We show […]

Just-In-Time Enrollment for Oncology Trials: Get to First Patient In Faster & Mitigate Non-Enrolling Sites

January 12, 2018

Despite scientific advances, oncology clinical trials are still challenged by delayed trial timelines, slow site activation and poor patient enrollment. To overcome these barriers, we need to redefine the enrollment paradigm. A new trial methodology has been developed that addresses these challenges and provides sponsors with the enrollment and budget solution needed to more effectively […]

2018 Healthcare Predictions

November 29, 2017

Every year, InCrowd surveys physicians across a wide range of specialties to better understand their perspective on healthcare policies and trends, and learn what they think will happen in the year ahead. Join us as we take a look at physician predictions and insights for 2018, and how they compare to years past. In the […]

How to avoid the 5 patient enrollment mistakes that delay clinical trials

November 16, 2017

Ever wonder why 80% of clinical trials are delayed? The top reason is unfulfilled enrollment, and there are specific reasons why this happens with so many trials This webinar will reveal 5 patient enrollment errors that stall enrollment timelines in trial after trial. More importantly, it will provide useful advice, based on proven methods, for […]

Improving Time-to-Market and Clinical Quality of Studies with Video EEG Protocol

October 24, 2017

Drug development costs for Central Nervous System (CNS) trials are more complex and costly for pharmaceutical companies and often take longer to develop than other medicines. Failed studies often occur later in development when costs are the highest. For compound efficacy and safety that is being measured with electroencephalography (EEG), technical and recording difficulties simply […]

Digitizing Clinical Research Processes – The New Frontier

October 6, 2017

One in three people will be diagnosed with cancer in their lifetime, but according to the NIH, only 3-5% of adult cancer patients participate in clinical trials. Advancing therapies in oncology and other disease areas is at the forefront of academic and commercial R&D. But enrollment and site initiation is often hindered by daunting, time […]

FEEDBACK